Volume 19: Issue 3 (Dec 2020): Disorders of Divalent Ions, Renal Bone Disease and Nephrolithiasis

Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697–701, 1974 PubMed

• Crossref
Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697–701, 1974 PubMed10.1056/NEJM197403282901301)| false
• Search Google Scholar
• Export Citation

Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S, et al.: Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci 18: 2918–2926, 2014 PubMed

Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S, : Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci 18: 2918–2926, 2014 PubMed)| false
• Search Google Scholar
• Export Citation

London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731–1740, 2003 PubMed

• Crossref
London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731–1740, 2003 PubMed10.1093/ndt/gfg414)| false
• Search Google Scholar
• Export Citation

Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, et al.: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293: 1737–1745, 2005 PubMed

• Crossref
Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, : Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293: 1737–1745, 2005 PubMed10.1001/jama.293.14.1737)| false
• Search Google Scholar
• Export Citation

Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, et al.: Multilineage potential of cells from the artery wall. Circulation 108: 2505–2510, 2003 PubMed

• Crossref
Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, : Multilineage potential of cells from the artery wall. Circulation 108: 2505–2510, 2003 PubMed10.1161/01.CIR.0000096485.64373.C5)| false
• Search Google Scholar
• Export Citation

Chen NX, Kiattisunthorn K, O’Neill KD, Chen X, Moorthi RN, Gattone VH 2nd, et al.: Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One 8: e64558, 2013 PubMed

• Crossref
Chen NX, Kiattisunthorn K, O’Neill KD, Chen X, Moorthi RN, Gattone VH 2nd, : Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One 8: e64558, 2013 PubMed10.1371/journal.pone.0064558)| false
• Search Google Scholar
• Export Citation

O’Neill WC: The fallacy of the calcium-phosphorus product. Kidney Int 72: 792–796, 2007 PubMed

• Crossref
O’Neill WC: The fallacy of the calcium-phosphorus product. Kidney Int 72: 792–796, 2007 PubMed10.1038/sj.ki.5002412)| false
• Search Google Scholar
• Export Citation

Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, et al.: Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305: 1119–1127, 2011 PubMed

• Crossref
Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, : Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305: 1119–1127, 2011 PubMed10.1001/jama.2011.308)| false
• Search Google Scholar
• Export Citation

Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, et al.: Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 103: e28–e34, 2008 PubMed

• Crossref
Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, : Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 103: e28–e34, 2008 PubMed10.1161/CIRCRESAHA.108.181305)| false
• Search Google Scholar
• Export Citation

Sage AP, Lu J, Tintut Y, Demer LL: Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79: 414–422, 2011 PubMed

• Crossref
Sage AP, Lu J, Tintut Y, Demer LL: Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79: 414–422, 2011 PubMed10.1038/ki.2010.390)| false
• Search Google Scholar
• Export Citation

Viegas CSB, Santos L, Macedo AL, Matos AA, Silva AP, Neves PL, et al.: Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein). Arterioscler Thromb Vasc Biol 38: 575–587, 2018 PubMed

• Crossref
Viegas CSB, Santos L, Macedo AL, Matos AA, Silva AP, Neves PL, : Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein). Arterioscler Thromb Vasc Biol 38: 575–587, 2018 PubMed10.1161/ATVBAHA.117.310578)| false
• Search Google Scholar
• Export Citation

Chen NX, O’Neill KD, Moe SM: Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways. Kidney Int 93: 343–354, 2018 PubMed

• Crossref
Chen NX, O’Neill KD, Moe SM: Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways. Kidney Int 93: 343–354, 2018 PubMed10.1016/j.kint.2017.07.019)| false
• Search Google Scholar
• Export Citation

Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, et al.: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357–366, 2003 PubMed

• Crossref
Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, : The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357–366, 2003 PubMed10.1172/JCI17202)| false
• Search Google Scholar
• Export Citation

Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, et al.: The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 5: 568–575, 2010 PubMed

• Crossref
Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, : The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 5: 568–575, 2010 PubMed10.2215/CJN.07081009)| false
• Search Google Scholar
• Export Citation

Willems BA, Furmanik M, Caron MMJ, Chatrou MLL, Kusters DHM, Welting TJM, et al.: Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling. Sci Rep 8: 4961, 2018 PubMed

• Crossref
Willems BA, Furmanik M, Caron MMJ, Chatrou MLL, Kusters DHM, Welting TJM, : Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling. Sci Rep 8: 4961, 2018 PubMed10.1038/s41598-018-23353-y)| false
• Search Google Scholar
• Export Citation

Silva AP, Viegas CS, Mendes F, Macedo A, Guilherme P, Tavares N, et al.: Gla-Rich Protein (GRP) as an Early and Novel Marker of Vascular Calcification and Kidney Dysfunction in Diabetic Patients with CKD: A Pilot Cross-Sectional Study. J Clin Med 9: E635, 2020 PubMed

• Crossref
Silva AP, Viegas CS, Mendes F, Macedo A, Guilherme P, Tavares N, : Gla-Rich Protein (GRP) as an Early and Novel Marker of Vascular Calcification and Kidney Dysfunction in Diabetic Patients with CKD: A Pilot Cross-Sectional Study. J Clin Med 9: E635, 2020 PubMed10.3390/jcm9030635)| false
• Search Google Scholar
• Export Citation

Jansen RS, Duijst S, Mahakena S, Sommer D, Szeri F, Váradi A, et al.: ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report. Arterioscler Thromb Vasc Biol 34: 1985–1989, 2014 PubMed

• Crossref
Jansen RS, Duijst S, Mahakena S, Sommer D, Szeri F, Váradi A, : ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report. Arterioscler Thromb Vasc Biol 34: 1985–1989, 2014 PubMed10.1161/ATVBAHA.114.304017)| false
• Search Google Scholar
• Export Citation

Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, et al.: PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 158: 543–554, 2001 PubMed

• Crossref
Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, : PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 158: 543–554, 2001 PubMed10.1016/S0002-9440(10)63996-X)| false
• Search Google Scholar
• Export Citation

Sheen CR, Kuss P, Narisawa S, Yadav MC, Nigro J, Wang W, et al.: Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res 30: 824–836, 2015 PubMed

• Crossref
Sheen CR, Kuss P, Narisawa S, Yadav MC, Nigro J, Wang W, : Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res 30: 824–836, 2015 PubMed10.1002/jbmr.2420)| false
• Search Google Scholar
• Export Citation

Riser BL, Barreto FC, Rezg R, Valaitis PW, Cook CS, White JA, et al.: Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transplant 26: 3349–3357, 2011 PubMed

• Crossref
Riser BL, Barreto FC, Rezg R, Valaitis PW, Cook CS, White JA, : Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transplant 26: 3349–3357, 2011 PubMed10.1093/ndt/gfr039)| false
• Search Google Scholar
• Export Citation

Lomashvili KA, Khawandi W, O’Neill WC: Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16: 2495–2500, 2005 PubMed

• Crossref
Lomashvili KA, Khawandi W, O’Neill WC: Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16: 2495–2500, 2005 PubMed10.1681/ASN.2004080694)| false
• Search Google Scholar
• Export Citation

Tani T, Fujiwara M, Orimo H, Shimizu A, Narisawa S, Pinkerton AB, et al.: Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model. J Pathol 250: 30–41, 2020 PubMed

• Crossref
Tani T, Fujiwara M, Orimo H, Shimizu A, Narisawa S, Pinkerton AB, : Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model. J Pathol 250: 30–41, 2020 PubMed10.1002/path.5346)| false
• Search Google Scholar
• Export Citation

Perelló J, Gómez M, Ferrer MD, Rodríguez NY, Salcedo C, Buades JM, et al.: SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels. J Nephrol 31: 287–296, 2018 PubMed

• Crossref
Perelló J, Gómez M, Ferrer MD, Rodríguez NY, Salcedo C, Buades JM, : SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels. J Nephrol 31: 287–296, 2018 PubMed10.1007/s40620-018-0471-9)| false
• Search Google Scholar
• Export Citation

Brandenburg VM, Sinha S, Torregrosa JV, Garg R, Miller S, Canals AZ, et al.: Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis. J Nephrol 32: 811–821, 2019 PubMed

• Crossref
Brandenburg VM, Sinha S, Torregrosa JV, Garg R, Miller S, Canals AZ, : Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis. J Nephrol 32: 811–821, 2019 PubMed10.1007/s40620-019-00631-0)| false
• Search Google Scholar
• Export Citation

Kang JH, Toita R, Asai D, Yamaoka T, Murata M: Reduction of inorganic phosphate-induced human smooth muscle cells calcification by inhibition of protein kinase A and p38 mitogen-activated protein kinase. Heart Vessels 29: 718–722, 2014 PubMed

• Crossref
Kang JH, Toita R, Asai D, Yamaoka T, Murata M: Reduction of inorganic phosphate-induced human smooth muscle cells calcification by inhibition of protein kinase A and p38 mitogen-activated protein kinase. Heart Vessels 29: 718–722, 2014 PubMed10.1007/s00380-013-0427-x)| false
• Search Google Scholar
• Export Citation

Li X, Yang HY, Giachelli CM: BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199: 271–277, 2008 PubMed

• Crossref
Li X, Yang HY, Giachelli CM: BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199: 271–277, 2008 PubMed10.1016/j.atherosclerosis.2007.11.031)| false
• Search Google Scholar
• Export Citation

Hruska KA, Lanske B, Moe OW: Crosstalk between kidney and bone - Bench to bedside. Bone 100: 1–3, 2017 PubMed

• Crossref
Hruska KA, Lanske B, Moe OW: Crosstalk between kidney and bone - Bench to bedside. Bone 100: 1–3, 2017 PubMed10.1016/j.bone.2017.03.046)| false
• Search Google Scholar
• Export Citation

Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, et al.: CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 25: 1760–1773, 2014 PubMed

• Crossref
Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, : CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 25: 1760–1773, 2014 PubMed10.1681/ASN.2013080818)| false
• Search Google Scholar
• Export Citation

Moe SM, Chen NX, Newman CL, Organ JM, Kneissel M, Kramer I, et al.: Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 30: 499–509, 2015 PubMed

• Crossref
Moe SM, Chen NX, Newman CL, Organ JM, Kneissel M, Kramer I, : Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 30: 499–509, 2015 PubMed10.1002/jbmr.2372)| false
• Search Google Scholar
• Export Citation

Evenepoel P, D’Haese P, Brandenburg V: Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88: 235–240, 2015 PubMed

• Crossref
Evenepoel P, D’Haese P, Brandenburg V: Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88: 235–240, 2015 PubMed10.1038/ki.2015.156)| false
• Search Google Scholar
• Export Citation

Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, et al.: The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int 93: 147–158, 2018 PubMed

• Crossref
Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, : The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int 93: 147–158, 2018 PubMed10.1016/j.kint.2017.06.016)| false
• Search Google Scholar
• Export Citation

Gravesen E, Lerche Mace M, Nordholm A, Hofman-Bang J, Hruska K, Haagen Nielsen C, et al.: Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification. PLoS One 13: e0190820, 2018 PubMed

• Crossref
Gravesen E, Lerche Mace M, Nordholm A, Hofman-Bang J, Hruska K, Haagen Nielsen C, : Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification. PLoS One 13: e0190820, 2018 PubMed10.1371/journal.pone.0190820)| false
• Search Google Scholar
• Export Citation

Agapova OA, Fang Y, Sugatani T, Seifert ME, Hruska KA: Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. Kidney Int 89: 1231–1243, 2016 PubMed

• Crossref
Agapova OA, Fang Y, Sugatani T, Seifert ME, Hruska KA: Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. Kidney Int 89: 1231–1243, 2016 PubMed10.1016/j.kint.2016.02.002)| false
• Search Google Scholar
• Export Citation

Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, et al.: Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22: 124–136, 2011 PubMed

• Crossref
Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, : Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22: 124–136, 2011 PubMed10.1681/ASN.2009121311)| false
• Search Google Scholar
• Export Citation

Shroff R, Shanahan CM: Klotho: an elixir of youth for the vasculature? J Am Soc Nephrol 22: 5–7, 2011 PubMed

• Crossref
Shroff R, Shanahan CM: Klotho: an elixir of youth for the vasculature? J Am Soc Nephrol 22: 5–7, 2011 PubMed10.1681/ASN.2010111190)| false
• Search Google Scholar
• Export Citation

Viegas C, Araújo N, Marreiros C, Simes D: The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging (Albany NY) 11: 4274–4299, 2019 PubMed

• Crossref
Viegas C, Araújo N, Marreiros C, Simes D: The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging (Albany NY) 11: 4274–4299, 2019 PubMed10.18632/aging.102046)| false
• Search Google Scholar
• Export Citation

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group: KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011) 7: 1–59, 2017 PubMed

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group: KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011) 7: 1–59, 2017 PubMed)| false
• Search Google Scholar
• Export Citation

Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, et al.: Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 49: 417–425, 2007 PubMed

• Crossref
Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, : Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 49: 417–425, 2007 PubMed10.1053/j.ajkd.2006.12.017)| false
• Search Google Scholar
• Export Citation

Lewis JR, Wong G, Taverniti A, Vucak-Dzumhur M, Elder GJ: Association between Aortic Calcification, Cardiovascular Events, and Mortality in Kidney and Pancreas-Kidney Transplant Recipients. Am J Nephrol 50: 177–186, 2019 PubMed

• Crossref
Lewis JR, Wong G, Taverniti A, Vucak-Dzumhur M, Elder GJ: Association between Aortic Calcification, Cardiovascular Events, and Mortality in Kidney and Pancreas-Kidney Transplant Recipients. Am J Nephrol 50: 177–186, 2019 PubMed10.1159/000502328)| false
• Search Google Scholar
• Export Citation

Pencak P, Czerwieńska B, Ficek R, Wyskida K, Kujawa-Szewieczek A, Olszanecka-Glinianowicz M, et al.: Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol 14: 10, 2013 PubMed

• Crossref
Pencak P, Czerwieńska B, Ficek R, Wyskida K, Kujawa-Szewieczek A, Olszanecka-Glinianowicz M, : Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol 14: 10, 2013 PubMed10.1186/1471-2369-14-10)| false
• Search Google Scholar
• Export Citation

Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M, et al.: Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 30: 2289–2296, 2010 PubMed

• Crossref
Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M, : Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 30: 2289–2296, 2010 PubMed10.1161/ATVBAHA.110.208181)| false
• Search Google Scholar
• Export Citation

Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW: New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132: 245–250, 1997 PubMed

• Crossref
Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW: New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132: 245–250, 1997 PubMed10.1016/S0021-9150(97)00106-8)| false
• Search Google Scholar
• Export Citation

Chau K, Martinez G, Elder GJ: Vascular calcification in patients undergoing kidney and simultaneous pancreas-kidney transplantation. Nephrology (Carlton) 19: 275–281, 2014 PubMed

• Crossref
Chau K, Martinez G, Elder GJ: Vascular calcification in patients undergoing kidney and simultaneous pancreas-kidney transplantation. Nephrology (Carlton) 19: 275–281, 2014 PubMed10.1111/nep.12212)| false
• Search Google Scholar
• Export Citation

Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, et al.: A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19: 1480–1488, 2004 PubMed

• Crossref
Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, : A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19: 1480–1488, 2004 PubMed10.1093/ndt/gfh217)| false
• Search Google Scholar
• Export Citation

Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients. Clin J Am Soc Nephrol 4: 119–127, 2009 PubMed

• Crossref
Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients. Clin J Am Soc Nephrol 4: 119–127, 2009 PubMed10.2215/CJN.03410708)| false
• Search Google Scholar
• Export Citation

Aleksova J, Kurniawan S, Vucak-Dzumhur M, Kerr P, Ebeling PR, Milat F, et al.: Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis. Bone 113: 118–123, 2018 PubMed

• Crossref
Aleksova J, Kurniawan S, Vucak-Dzumhur M, Kerr P, Ebeling PR, Milat F, : Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis. Bone 113: 118–123, 2018 PubMed10.1016/j.bone.2018.05.014)| false
• Search Google Scholar
• Export Citation

Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, et al.: Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol 17: 521–527, 2006 PubMed

• Crossref
Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, : Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol 17: 521–527, 2006 PubMed10.1681/ASN.2005060627)| false
• Search Google Scholar
• Export Citation

Leskinen Y, Paana T, Saha H, Groundstroem K, Lehtimäki T, Kilpinen S, et al.: Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis 18: 429–438, 2009 PubMed

Leskinen Y, Paana T, Saha H, Groundstroem K, Lehtimäki T, Kilpinen S, : Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis 18: 429–438, 2009 PubMed)| false
• Search Google Scholar
• Export Citation

Farrar DJ, Bond MG, Riley WA, Sawyer JK: Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 83: 1754–1763, 1991 PubMed

• Crossref
Farrar DJ, Bond MG, Riley WA, Sawyer JK: Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 83: 1754–1763, 1991 PubMed10.1161/01.CIR.83.5.1754)| false
• Search Google Scholar
• Export Citation

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al.; ESC Scientific Document Group: 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39: 3021–3104, 2018 PubMed

• Crossref
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, ; ESC Scientific Document Group: 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39: 3021–3104, 2018 PubMed10.1093/eurheartj/ehy339)| false
• Search Google Scholar
• Export Citation

Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, et al.: Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD. BMC Nephrol 18: 281, 2017 PubMed

• Crossref
Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, : Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD. BMC Nephrol 18: 281, 2017 PubMed10.1186/s12882-017-0705-4)| false
• Search Google Scholar
• Export Citation

Tholen S, Klofat K, Pan CR, Schmaderer C, Lutz J, Heemann U, et al.: Progression of aortic pulse wave velocity in patients with chronic kidney disease. J Clin Hypertens (Greenwich) 15: 833–838, 2013 PubMed

• Crossref
Tholen S, Klofat K, Pan CR, Schmaderer C, Lutz J, Heemann U, : Progression of aortic pulse wave velocity in patients with chronic kidney disease. J Clin Hypertens (Greenwich) 15: 833–838, 2013 PubMed10.1111/jch.12198)| false
• Search Google Scholar
• Export Citation

Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG: Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 55: 1110–1115, 2010 PubMed

• Crossref
Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG: Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 55: 1110–1115, 2010 PubMed10.1161/HYPERTENSIONAHA.109.143024)| false
• Search Google Scholar
• Export Citation

Lioufas N, Hawley CM, Cameron JD, Toussaint ND: Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review. Int J Hypertens 2019: 9189362, 2019 PubMed

• Crossref
Lioufas N, Hawley CM, Cameron JD, Toussaint ND: Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review. Int J Hypertens 2019: 9189362, 2019 PubMed10.1155/2019/9189362)| false
• Search Google Scholar
• Export Citation

Kamath TP, Prasad R, Allison MA, Criqui MC, Ix JH, Rifkin DE, et al.: Association of Ankle-Brachial and Toe-Brachial Indexes With Mortality in Patients With CKD. Kidney Med 2: 68–75, 2020 PubMed

• Crossref
Kamath TP, Prasad R, Allison MA, Criqui MC, Ix JH, Rifkin DE, : Association of Ankle-Brachial and Toe-Brachial Indexes With Mortality in Patients With CKD. Kidney Med 2: 68–75, 2020 PubMed10.1016/j.xkme.2019.11.001)| false
• Search Google Scholar
• Export Citation

Ono K, Tsuchida A, Kawai H, Matsuo H, Wakamatsu R, Maezawa A, et al.: Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 14: 1591–1598, 2003 PubMed

• Crossref
Ono K, Tsuchida A, Kawai H, Matsuo H, Wakamatsu R, Maezawa A, : Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 14: 1591–1598, 2003 PubMed10.1097/01.ASN.0000065547.98258.3D)| false
• Search Google Scholar
• Export Citation

Yoshitomi R, Nakayama M, Ura Y, Kuma K, Nishimoto H, Fukui A, et al.: Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis. Hypertens Res 37: 1050–1055, 2014 PubMed

• Crossref
Yoshitomi R, Nakayama M, Ura Y, Kuma K, Nishimoto H, Fukui A, : Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis. Hypertens Res 37: 1050–1055, 2014 PubMed10.1038/hr.2014.120)| false
• Search Google Scholar
• Export Citation

Gu X, Man C, Zhang H, Fan Y: High ankle-brachial index and risk of cardiovascular or all-cause mortality: A meta-analysis. Atherosclerosis 282: 29–36, 2019 PubMed

• Crossref
Gu X, Man C, Zhang H, Fan Y: High ankle-brachial index and risk of cardiovascular or all-cause mortality: A meta-analysis. Atherosclerosis 282: 29–36, 2019 PubMed10.1016/j.atherosclerosis.2018.12.028)| false
• Search Google Scholar
• Export Citation

Pasch A, Farese S, Gräber S, Wald J, Richtering W, Floege J, et al.: Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23: 1744–1752, 2012 PubMed

• Crossref
Pasch A, Farese S, Gräber S, Wald J, Richtering W, Floege J, : Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23: 1744–1752, 2012 PubMed10.1681/ASN.2012030240)| false
• Search Google Scholar
• Export Citation

Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, et al.: Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 25: 339–348, 2014 PubMed

• Crossref
Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, : Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 25: 339–348, 2014 PubMed10.1681/ASN.2013060635)| false
• Search Google Scholar
• Export Citation

Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, et al.; CRIC Study Investigators: Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis 73: 806–814, 2019 PubMed

• Crossref
Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, ; CRIC Study Investigators: Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis 73: 806–814, 2019 PubMed10.1053/j.ajkd.2019.01.024)| false
• Search Google Scholar
• Export Citation

Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, Arampatzis S, et al.: Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin J Am Soc Nephrol 12: 315–322, 2017 PubMed

• Crossref
Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, Arampatzis S, : Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin J Am Soc Nephrol 12: 315–322, 2017 PubMed10.2215/CJN.04720416)| false
• Search Google Scholar
• Export Citation

Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L: The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial. Clin J Am Soc Nephrol 13: 1373–1380, 2018 PubMed

• Crossref
Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L: The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial. Clin J Am Soc Nephrol 13: 1373–1380, 2018 PubMed10.2215/CJN.13921217)| false
• Search Google Scholar
• Export Citation

Lorenz G, Mayer CC, Bachmann Q, Stryeck S, Braunisch MC, Haller B, et al.: Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study. Nephrol Dial Transplant 33: 2043–2051, 2018 PubMed

• Crossref
Lorenz G, Mayer CC, Bachmann Q, Stryeck S, Braunisch MC, Haller B, : Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study. Nephrol Dial Transplant 33: 2043–2051, 2018 PubMed10.1093/ndt/gfy134)| false
• Search Google Scholar
• Export Citation

Ter Meulen KJ, Dekker MJE, Pasch A, Broers NJH, van der Sande FM, van der Net JB, et al.: Citric-acid dialysate improves the calcification propensity of hemodialysis patients: A multicenter prospective randomized cross-over trial. PLoS One 14: e0225824, 2019 PubMed

• Crossref
Ter Meulen KJ, Dekker MJE, Pasch A, Broers NJH, van der Sande FM, van der Net JB, : Citric-acid dialysate improves the calcification propensity of hemodialysis patients: A multicenter prospective randomized cross-over trial. PLoS One 14: e0225824, 2019 PubMed10.1371/journal.pone.0225824)| false
• Search Google Scholar
• Export Citation

Spiegel DM, Brady K: Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int 81: 1116–1122, 2012 PubMed

• Crossref
Spiegel DM, Brady K: Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int 81: 1116–1122, 2012 PubMed10.1038/ki.2011.490)| false
• Search Google Scholar
• Export Citation

Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, et al.: Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23: 1407–1415, 2012 PubMed

• Crossref
Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, : Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23: 1407–1415, 2012 PubMed10.1681/ASN.2012030223)| false
• Search Google Scholar
• Export Citation

Toussaint ND, Pedagogos E, Lioufas NM, Elder GJ, Pascoe EM, Badve SV, et al.; IMPROVE-CKD Trial Investigators: A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD). J Am Soc Nephrol 31: 2653–2666, 2020 PubMed

• Crossref
Toussaint ND, Pedagogos E, Lioufas NM, Elder GJ, Pascoe EM, Badve SV, ; IMPROVE-CKD Trial Investigators: A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD). J Am Soc Nephrol 31: 2653–2666, 2020 PubMed10.1681/ASN.2020040411)| false
• Search Google Scholar
• Export Citation

Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, et al.: Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials. Am J Kidney Dis 68: 691–702, 2016 PubMed

• Crossref
Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, : Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials. Am J Kidney Dis 68: 691–702, 2016 PubMed10.1053/j.ajkd.2016.05.015)| false
• Search Google Scholar
• Export Citation

Patel L, Bernard LM, Elder GJ: Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Clin J Am Soc Nephrol 11: 232–244, 2016 PubMed

• Crossref
Patel L, Bernard LM, Elder GJ: Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Clin J Am Soc Nephrol 11: 232–244, 2016 PubMed10.2215/CJN.06800615)| false
• Search Google Scholar
• Export Citation

Block GA, Block MS, Smits G, Mehta R, Isakova T, Wolf M, et al.: A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. J Am Soc Nephrol 30: 1495–1504, 2019 PubMed

• Crossref
Block GA, Block MS, Smits G, Mehta R, Isakova T, Wolf M, : A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. J Am Soc Nephrol 30: 1495–1504, 2019 PubMed10.1681/ASN.2018101016)| false
• Search Google Scholar
• Export Citation

Becs G, Zarjou A, Agarwal A, Kovács KÉ, Becs Á, Nyitrai M, et al.: Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells. J Cell Mol Med 20: 217–230, 2016 PubMed

• Crossref
Becs G, Zarjou A, Agarwal A, Kovács KÉ, Becs Á, Nyitrai M, : Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells. J Cell Mol Med 20: 217–230, 2016 PubMed10.1111/jcmm.12682)| false
• Search Google Scholar
• Export Citation

Ciceri P, Elli F, Braidotti P, Falleni M, Tosi D, Bulfamante G, et al.: Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis. Atherosclerosis 254: 93–101, 2016 PubMed

• Crossref
Ciceri P, Elli F, Braidotti P, Falleni M, Tosi D, Bulfamante G, : Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis. Atherosclerosis 254: 93–101, 2016 PubMed10.1016/j.atherosclerosis.2016.09.071)| false
• Search Google Scholar
• Export Citation

de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, et al.: Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 25: 3707–3717, 2010 PubMed

• Crossref
de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, : Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 25: 3707–3717, 2010 PubMed10.1093/ndt/gfq292)| false
• Search Google Scholar
• Export Citation

Ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF: Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep 8: 2069, 2018 PubMed

• Crossref
Ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF: Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep 8: 2069, 2018 PubMed10.1038/s41598-018-20241-3)| false
• Search Google Scholar
• Export Citation

Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, et al.: Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 56: 453–462, 2010 PubMed

• Crossref
Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, : Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 56: 453–462, 2010 PubMed10.1161/HYPERTENSIONAHA.110.152058)| false
• Search Google Scholar
• Export Citation

Montes de Oca A, Guerrero F, Martinez-Moreno JM, Madueño JA, Herencia C, Peralta A, et al.: Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One 9: e89525, 2014 PubMed

• Crossref
Montes de Oca A, Guerrero F, Martinez-Moreno JM, Madueño JA, Herencia C, Peralta A, : Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One 9: e89525, 2014 PubMed10.1371/journal.pone.0089525)| false
• Search Google Scholar
• Export Citation

Herencia C, Rodríguez-Ortiz ME, Muñoz-Castañeda JR, Martinez-Moreno JM, Canalejo R, Montes de Oca A, et al.: Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx. Eur J Clin Invest 45: 1129–1144, 2015 PubMed